Pair Name | Eriocalyxin B, Gemcitabine | ||
Phytochemical Name | Eriocalyxin B (PubChem CID: 16202215 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Eriocalyxin B, Gemcitabine | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Phosphorylation | MAPK8 | hsa5599 | |
Down-regulation | Phosphorylation | NFKB1 | hsa4790 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Down-regulation | Phosphorylation | PDK1 | hsa5163 | |
In Vitro Model | PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 |
SW1990 | Pancreatic adenocarcinoma | Homo sapiens (Human) | CVCL_1723 | |
Capan-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0237 | |
Capan-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0026 | |
Result | Gem and EriB (or Isodon extract) taken together in combination regulated PDK1/AKT1/caspase and JNK signaling and promoted apoptosis synergistically, which may contribute to the much increased anti-proliferative activity compared to either agent alone. |
No. | Title | Href |
---|---|---|
1 | Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Phytomedicine. 2018 May 15;44:56-64. doi: 10.1016/j.phymed.2018.03.055. | Click |